NL300161I2 - Carbostyrilderivaten. - Google Patents

Carbostyrilderivaten.

Info

Publication number
NL300161I2
NL300161I2 NL300161C NL300161C NL300161I2 NL 300161 I2 NL300161 I2 NL 300161I2 NL 300161 C NL300161 C NL 300161C NL 300161 C NL300161 C NL 300161C NL 300161 I2 NL300161 I2 NL 300161I2
Authority
NL
Netherlands
Prior art keywords
carbostyril derivatives
carbostyril
derivatives
Prior art date
Application number
NL300161C
Other languages
English (en)
Other versions
NL300161I1 (nl
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17576714&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL300161(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of NL300161I1 publication Critical patent/NL300161I1/nl
Publication of NL300161I2 publication Critical patent/NL300161I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL300161C 1988-10-31 2004-10-18 Carbostyrilderivaten. NL300161I2 (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27695388 1988-10-31

Publications (2)

Publication Number Publication Date
NL300161I1 NL300161I1 (nl) 2004-12-01
NL300161I2 true NL300161I2 (nl) 2005-02-01

Family

ID=17576714

Family Applications (1)

Application Number Title Priority Date Filing Date
NL300161C NL300161I2 (nl) 1988-10-31 2004-10-18 Carbostyrilderivaten.

Country Status (10)

Country Link
US (1) US5006528A (nl)
EP (1) EP0367141B1 (nl)
KR (1) KR0138529B1 (nl)
CN (1) CN1028104C (nl)
DE (2) DE122004000043I2 (nl)
DK (1) DK168485B1 (nl)
ES (1) ES2084594T3 (nl)
HK (1) HK1002706A1 (nl)
MX (1) MX9202934A (nl)
NL (1) NL300161I2 (nl)

Families Citing this family (169)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
AR032641A1 (es) * 2001-01-29 2003-11-19 Otsuka Pharma Co Ltd Agonista de subtipo de receptor 5-ht 1a.
US7053092B2 (en) 2001-01-29 2006-05-30 Otsuka Pharmaceutical Co., Ltd. 5-HT1a receptor subtype agonist
MY129350A (en) * 2001-04-25 2007-03-30 Bristol Myers Squibb Co Aripiprazole oral solution
US8703772B2 (en) 2001-09-25 2014-04-22 Otsuka Pharmaceutical Co., Ltd. Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
PE20030445A1 (es) * 2001-09-25 2003-07-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
TWI324074B (en) * 2001-10-09 2010-05-01 Bristol Myers Squibb Co Flashmelt oral dosage formulation
SE0200301D0 (sv) * 2002-02-01 2002-02-01 Axon Biochemicals Bv Thio-carbostyril derivative
EP1542668B1 (en) 2002-08-20 2009-04-15 Bristol-Myers Squibb Company Aripiprazole complex formulation and method
GB0220581D0 (en) 2002-09-04 2002-10-09 Novartis Ag Organic Compound
AU2003291757A1 (en) * 2002-11-08 2004-06-03 Bristol-Myers Squibb Company Formulations of low solubility bioactive agents and processes for making the same
AR042806A1 (es) * 2002-12-27 2005-07-06 Otsuka Pharma Co Ltd Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo
KR100858852B1 (ko) 2002-12-27 2008-09-17 오쓰까 세이야꾸 가부시키가이샤 기분 장애 치료용 카르보스티릴 유도체 및 세로토닌 재흡수억제제
MXPA04002519A (es) 2003-01-09 2005-04-04 Otsuka Pharma Co Ltd Proceso para preparar aripiprazol.
WO2004064752A2 (en) * 2003-01-22 2004-08-05 Alkermes Controlled Therapeutics, Inc. Method of preparing sustained release microparticles
EP1606262A1 (en) * 2003-03-21 2005-12-21 Hetero Drugs Limited Novel crystalline forms of aripiprazole
WO2004106322A2 (en) * 2003-04-25 2004-12-09 Cadila Healthcare Limited Polymorphs of aripiprazole
CA2428237C (en) * 2003-05-08 2010-07-20 Delmar Chemicals Inc. Process for the preparation of carbostyril derivatives
JP2006528676A (ja) * 2003-05-16 2006-12-21 ファイザー・プロダクツ・インク 非定形型抗精神病薬と、ｇａｂａ調節薬及び／又は抗痙攣薬の治療上の組合せ
MXPA05012538A (es) 2003-05-23 2006-02-22 Otsuka Pharma Co Ltd Derivados de carbostirilo y estabilizantes del estado de animo para trastornos del mismo.
WO2005009990A1 (en) * 2003-07-25 2005-02-03 Hetero Drugs Limited Aripiprazole crystalline forms
US20050031713A1 (en) * 2003-08-06 2005-02-10 Elliot Ehrich Methods for administering active agents to CYP3A4 sensitive patients
US20050032781A1 (en) * 2003-08-06 2005-02-10 Elliot Ehrich Methods for administering active agents to CYP 2D6 sensitive patients
US20050032811A1 (en) * 2003-08-06 2005-02-10 Josiah Brown Methods for administering aripiprazole
US6987111B2 (en) 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
US7160888B2 (en) * 2003-08-22 2007-01-09 Warner Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
PT1673370E (pt) * 2003-10-16 2009-11-05 Symed Labs Ltd Forma cristalina de linezolida
PL1675573T4 (pl) 2003-10-23 2016-04-29 Otsuka Pharma Co Ltd Sterylny preparat do wstrzykiwań arypiprazolu o kontrolowanym uwalnianiu i sposób
TWI371274B (en) * 2003-10-23 2012-09-01 Bristol Myers Squibb Co Process for making sterile aripiprazole of desired mean particle size
GB0326148D0 (en) 2003-11-10 2003-12-17 Lilly Co Eli Morpholine derivatives
US7714129B2 (en) * 2003-12-16 2010-05-11 Teva Pharmaceutical Industries Ltd. Methods of preparing anhydrous aripiprazole form II
JP5546717B2 (ja) 2003-12-16 2014-07-09 テバ ファーマシューティカル インダストリーズ リミティド アリピプラゾール結晶質形態を調製する方法
CN1304373C (zh) * 2003-12-25 2007-03-14 成都康弘科技实业（集团）有限公司 阿立哌唑的制备方法和中间体
EP1711466A1 (en) * 2004-02-05 2006-10-18 Teva Pharmaceutical Industries Ltd Process for preparing aripiprazole
EP1765782A1 (en) * 2004-02-05 2007-03-28 Teva Pharmaceutical Industries Ltd Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril
CN100497325C (zh) * 2004-04-21 2009-06-10 齐鲁制药有限公司 哌嗪衍生物及其在制备喹啉酮衍生物中的用途
US7507823B2 (en) * 2004-05-06 2009-03-24 Bristol-Myers Squibb Company Process of making aripiprazole particles
BRPI0510942A (pt) * 2004-05-11 2007-07-17 Pfizer Prod Inc combinação de antipsicóticos atìpicos e antagonistas do receptor 5-ht1b
AR049401A1 (es) 2004-06-18 2006-07-26 Novartis Ag Aza-biciclononanos
WO2006012237A2 (en) * 2004-06-25 2006-02-02 Shanghai Institute Of Pharmaceutical Industry Aripiprazole crystaline forms and associated methods
TW200616608A (en) * 2004-07-09 2006-06-01 Forest Laboratories Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
GB0415746D0 (en) 2004-07-14 2004-08-18 Novartis Ag Organic compounds
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
US20090198059A1 (en) * 2004-09-13 2009-08-06 Chava Satyanarayana Process for the preparation of polymorphs, solvates of aripiprazole using aripirazole acid salts
US7872132B2 (en) * 2004-10-08 2011-01-18 Suven Life Sciences Limited Intermediates useful for the preparation of aripiprazole and methods for the preparation of the novel intermediates and aripiprazole
DE102005048695A1 (de) * 2004-10-12 2006-05-18 Chemagis Ltd. Verfahren zur Herstellung und Reinigung von Carbostyrilverbindungen wie beispielsweise Aripiprazol und 7-(4-Halobutoxy)-3,4-dihydro-2(1H)-quinolinonen
DE102005048694A1 (de) * 2004-10-12 2006-05-18 Chemagis Ltd. Verbesserte Verfahren zur Herstellung von 7-Hydroxy-3,4-dihydro-2(1H)-quinolinon und dessen Verwendung in der Herstellung von Aripiprazol
GB0424564D0 (en) 2004-11-05 2004-12-08 Novartis Ag Organic compounds
CN101087760B (zh) * 2004-11-18 2011-09-28 斯索恩有限公司 结晶的阿立哌唑溶剂化物
WO2006053781A1 (en) * 2004-11-18 2006-05-26 Synthon B.V. Process of making crystalline aripiprazole
CN1303068C (zh) * 2005-01-11 2007-03-07 中国人民解放军第二军医大学 一种阿立哌唑的制备方法
EP1844036B1 (en) * 2005-01-27 2015-09-23 Sandoz Ag Process for the preparation of aripiprazole
EP1686117A1 (en) * 2005-01-27 2006-08-02 Sandoz AG Polymorph and solvates of aripiprazole
EP1686126A1 (en) * 2005-01-27 2006-08-02 Sandoz AG Salts of aripiprazole
CZ300456B6 (cs) * 2005-02-15 2009-05-27 Zentiva, A. S. Zpusob prípravy vinanu aripiprazolu v krystalické forme
CZ300352B6 (cs) * 2005-02-15 2009-04-29 Zentiva, A. S. Zpusob prípravy fosforecnanu aripiprazolu
WO2006090272A1 (en) * 2005-02-22 2006-08-31 Warner-Lambert Company Llc Isoquinoline [1,8]naphthyridin-2-ones and related compounds for treatment of schizophrenia
EP1858855B2 (en) † 2005-03-17 2021-03-03 Synthon B.V. Process of making crystalline type ii aripiprazole
WO2006097344A1 (en) * 2005-03-17 2006-09-21 Synthon B.V. Pharmaceutical tablets of crystalline type ii aripiprazole
MX2007012083A (es) * 2005-04-01 2007-11-20 Warner Lambert Co Tetrahidro-piridoazepin-8-onas y compuestos relacionados para el tratamiento de la esquizofrenia.
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
CZ300351B6 (cs) * 2005-05-26 2009-04-29 Zentiva, A. S. Zpusob prípravy 7-hydroxy-3,4-dihydrokarbostyrilu
CN100432053C (zh) * 2005-06-07 2008-11-12 上海医药工业研究院 阿立哌唑晶型及其制备方法
HUP0500683A3 (en) * 2005-07-14 2009-03-30 Egis Gyogyszergyar Nyilvanosan New arylpiprazole salts for producing pharmaceutical composition
AR055203A1 (es) 2005-08-31 2007-08-08 Otsuka Pharma Co Ltd Derivados de benzotiofeno con propiedades antipsicoticas
JP2009508859A (ja) * 2005-09-15 2009-03-05 エラン ファーマ インターナショナル リミテッド ナノ粒子アリピプラゾール製剤
JP2008521835A (ja) 2005-09-29 2008-06-26 テバ ファーマシューティカル インダストリーズ リミティド 無水アリピプラゾールフォームｉｉの調製方法
CZ299485B6 (cs) * 2005-10-11 2008-08-13 Zentiva, A. S. Zpusob výroby aripiprazolu
GB0525672D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
GB0525673D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
WO2007075871A2 (en) * 2005-12-22 2007-07-05 Teva Pharmaceutical Industries Ltd. Processes for reducing particle size of aripiprazole
US20070149782A1 (en) * 2005-12-23 2007-06-28 Michael Brand Methods of preparing a crystalline form of 7-(4-chlorobutoxy)-3,4-dihydro-2(1h)-quinolinone and the use thereof in the synthesis of Aripiprazole
WO2007092779A2 (en) * 2006-02-03 2007-08-16 Dr. Reddy's Laboratories Ltd. Aripiprazole co-crystals
EP1988077A4 (en) 2006-02-23 2009-09-02 Shionogi & Co NUCLEIC HETEROCYCLIC DERIVATIVES SUBSTITUTED BY CYCLIC GROUPS
US20070213535A1 (en) * 2006-03-07 2007-09-13 Chemagis Ltd. Process for the manufacture of aripiprazole by using purified carbostyril compounds such as 7-(4-halobutoxy)-3,4-dihydro-2(1H)-quinolinones
US20060223820A1 (en) * 2006-03-21 2006-10-05 Chemagis Ltd. Crystalline aripiprazole salts and processes for preparation and purification thereof
WO2007113846A1 (en) * 2006-04-03 2007-10-11 Alembic Limited A process for the preparation of aripiprazole
EP1845088B1 (en) * 2006-04-10 2009-07-22 Ranbaxy Laboratories Limited An improved process for the preparation of aripipirazole
ATE523602T1 (de) 2006-06-12 2011-09-15 Hadasit Med Res Service Mit durch antipsychotika induzierten extrapyramidalen symptomen assoziierte rgs2- genotypen
WO2007148191A2 (en) * 2006-06-20 2007-12-27 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of aripiprazole
WO2008001188A2 (en) * 2006-06-29 2008-01-03 Cadila Pharmaceuticals Limited An improved process for the preparation of substantially pure aripiprazole
US7799790B2 (en) * 2006-07-20 2010-09-21 Helm Ag Amorphous aripiprazole and process for the preparation thereof
EP1880714A1 (en) * 2006-07-20 2008-01-23 Helm AG Amorphous Aripiprazole and Process for the Preparation thereof
TR200604349A2 (tr) 2006-08-15 2008-03-21 NOBEL İLAÇ SANAYii VE TiCARET A.Ş. Aripiprazol içeren farmasötik bileşimler
WO2008024481A2 (en) * 2006-08-24 2008-02-28 Concert Pharmaceuticals Inc. 3,4-dihydro-2 (1h) - quinolinone and 2 (1h)-quinolinone derivatives
ATE500226T1 (de) * 2006-09-22 2011-03-15 Krka Tovarna Zdravil D D Novo Mesto Aripiprazolhemifumarat und verfahren zu dessen herstellung
US20100113784A1 (en) * 2006-09-28 2010-05-06 Niraj Shyamlal Shah Process for preparing crystalline aripiprazole
WO2008051541A2 (en) * 2006-10-24 2008-05-02 Cambrex Charles City, Inc. Process for preparing anhydrous aripirazole type i
WO2008090632A1 (en) * 2007-01-26 2008-07-31 Otsuka Pharmaceutical Co., Ltd. Marker for detecting the proposed efficacy of treatment
EP1972628A1 (en) * 2007-03-21 2008-09-24 Schwarz Pharma Ag Indolizines and aza-analog derivatives thereof as CNS active compounds
TW200848041A (en) 2007-03-30 2008-12-16 Otsuka Pharma Co Ltd A medicament for treating schizophrenia comprising cilostazol
NZ582124A (en) 2007-05-21 2012-07-27 Reviva Pharmaceuticals Inc Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents
US20100130744A1 (en) * 2007-06-01 2010-05-27 Mahesh Nagarimadugu Process for the preparation of aripiprazole
US20080299216A1 (en) * 2007-06-01 2008-12-04 Protia, Llc Deuterium-enriched aripiprazole
ES2661037T3 (es) * 2007-07-31 2018-03-27 Otsuka Pharmaceutical Co., Ltd. Procedimientos para producir una suspensión de aripiprazol y una formulación liofilizada
GB2456183A (en) * 2008-01-04 2009-07-08 Gw Pharma Ltd Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament
ES2353444T3 (es) 2008-01-23 2011-03-02 Helm Ag Aripiprazol amorfo y procedimiento para su preparación.
CN101538252B (zh) * 2008-03-20 2011-04-20 成都康弘药业集团股份有限公司 阿立哌唑的制备方法及其中间体
US7964605B2 (en) * 2008-05-29 2011-06-21 Sk Holdings Co., Ltd. Phenyl piperazine compounds, pharmaceutical composition comprising the same, and use thereof
US7985752B2 (en) * 2008-05-29 2011-07-26 Sk Holdings Co., Ltd. Phenyl piperazine compounds, pharmaceutical composition including the same and use thereof
WO2010079506A2 (en) 2008-06-23 2010-07-15 Torrent Pharmaceuticals Ltd. Pharmaceutical composition of aripiprazole
JP2011526881A (ja) * 2008-06-25 2011-10-20 ファイザー・インク ジアリール化合物およびそれらの使用
EP2233471A1 (en) 2009-02-06 2010-09-29 Adamed Sp. z o.o. A salt of 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}-3,4.dihydro-2(1h)-quinolinone with 5-sulfosalicylic acid and its preparation process
WO2010106551A2 (en) * 2009-03-09 2010-09-23 Neuland Laboratories Ltd. A process for the manufacture of pure anhydrous aripiprazole form b
EP2238976B1 (en) 2009-04-03 2012-06-27 Hexal AG Oral films comprising 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro- 1H-quinolin-2-one base or salts or hydrates thereof
JP5664871B2 (ja) 2009-06-19 2015-02-04 株式会社 メドレックス アリピプラゾールと有機酸を有効成分とする外用剤組成物
JP5732453B2 (ja) * 2009-06-25 2015-06-10 アルカーメス ファーマ アイルランド リミテッド Ｎｈ酸性化合物のプロドラッグ
NZ597107A (en) 2009-06-25 2013-12-20 Alkermes Pharma Ireland Ltd Heterocyclic compounds for the treatment of neurological and psychological disorders
WO2011023796A1 (en) 2009-08-31 2011-03-03 Abbott Healthcare Products B.V. Bifeprunox for treating addiction
UA108862C2 (uk) 2009-09-11 2015-06-25 Терапевтичний агент проти хронічного болю
WO2011030213A1 (en) 2009-09-14 2011-03-17 Jubilant Organosys Limited Improved process for the preparation of 7.(4-bromobutoxy) 3,4-dihydrocarbostyril, a precursor of aripiprazole
US20120214820A1 (en) 2009-09-15 2012-08-23 Ratiopharm Gmbh Orally disintegrating pharmaceutical dosage form containing aripiprazole
TR201000948A1 (tr) 2010-02-09 2011-08-22 Sanovel İlaç San.Ve Ti̇c.A.Ş. Aripiprazol formülasyonları.
KR20130135820A (ko) 2010-06-16 2013-12-11 엠베라 뉴로 테라퓨틱스 인코포레이티드 중독，정신 장애 및 신경퇴행성 질환 치료용 조성물 및 방법
NZ604423A (en) 2010-06-24 2015-01-30 Alkermes Pharma Ireland Ltd Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
US9156822B2 (en) 2010-07-02 2015-10-13 The University Of North Carolina At Chapel Hill Functionally selective ligands of dopamine D2 receptors
LT3446565T (lt) 2010-08-23 2024-01-10 Alkermes Pharma Ireland Limited Antipsichozinių vaistų sukelto svorio augimo gydymo būdai
MX344235B (es) 2010-08-24 2016-12-07 Otsuka Pharmaceutical Co Ltd * Suspension y composicion en torta que contiene un derivado de carbostirilo y aceite de silicona y/o un derivado de aceite de silicona.
JP5916746B2 (ja) 2010-11-15 2016-05-11 エージンバイオ， インコーポレイテッド 認知障害を処置するためのピリダジン誘導体、組成物、および方法
AR083884A1 (es) 2010-11-16 2013-03-27 Otsuka Pharma Co Ltd Jeringa prellenable de doble camara y relleno de aripiprazol en la jeringa
US11648347B2 (en) 2011-01-24 2023-05-16 Otsuka Pharmaceutical Co., Ltd. Medical device containing a cake composition comprising aripiprazole as an active ingredient, and a cake composition comprising aripiprazole as an active ingredient
ES2972387T3 (es) 2011-03-18 2024-06-12 Alkermes Pharma Ireland Ltd Composiciones farmacéuticas que comprenden ésteres de sorbitán
WO2012131451A1 (en) 2011-03-30 2012-10-04 Jubilant Life Sciences Limited Process for producing aripiprazole in anhydrous type i crystals
KR101340214B1 (ko) 2011-03-31 2013-12-10 주식회사 대웅제약 무수 아리피프라졸 ⅱ형 결정의 제조방법
JO3410B1 (ar) 2011-06-07 2019-10-20 Otsuka Pharma Co Ltd تركيبة أريبيبرازول مجفف بالتبريد
TW201309651A (zh) 2011-06-29 2013-03-01 Otsuka Pharma Co Ltd 阿立哌唑（ａｒｉｐｉｐｒａｚｏｌｅ）無水物Ｂ形結晶微粒子之製造方法
GR1007722B (el) 2011-08-05 2012-10-18 Φαρματεν Αβεε, Μεθοδος για την παρασκευη της αριπιπραζολης
ES2715562T3 (es) 2011-12-15 2019-06-04 Alkermes Pharma Ireland Ltd Profármacos de compuestos de amina secundaria
CN103172563B (zh) * 2011-12-26 2015-03-25 北京京卫燕康药物研究所有限公司 小粒径的晶型i阿立哌唑的工业化制备
WO2014104989A1 (en) 2011-12-27 2014-07-03 Mahmut Bilgic Pharmaceutical compositions comprising aripiprazole
WO2013100878A1 (en) 2011-12-27 2013-07-04 Mahmut Bilgic Pharmaceutical formulations comprising aripiprazole
TW201343201A (zh) 2012-03-06 2013-11-01 Otsuka Pharma Co Ltd 持續釋放型口服固體製劑
NZ630643A (en) 2012-03-19 2017-08-25 Alkermes Pharma Ireland Ltd Pharmaceutical compositions comprising fatty acid esters
JP6219918B2 (ja) 2012-03-19 2017-10-25 アルカームス ファーマ アイルランド リミテッド グリセロールエステルを含む医薬組成物
EP2827866B1 (en) 2012-03-19 2023-05-03 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising benzyl alcohol
JOP20200109A1 (ar) 2012-04-23 2017-06-16 Otsuka Pharma Co Ltd مستحضر قابل للحقن
KR101571670B1 (ko) 2012-08-08 2015-11-25 주식회사 씨엠지제약 아리피프라졸을 포함하는 경구용 속용 필름 제제
ES2792149T3 (es) 2012-09-19 2020-11-10 Alkermes Pharma Ireland Ltd Composiciones farmacéuticas que tienen estabilidad de almacenamiento mejorada
US20140107130A1 (en) * 2012-10-11 2014-04-17 Antrim Pharmaceuticals, LLC Oral Solution Formulations of Aripiprazole
ES2637521T3 (es) 2012-10-16 2017-10-13 Arven Ilac Sanayi Ve Ticaret A.S. Formulaciones de aripiprazol
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
AR096131A1 (es) 2013-04-30 2015-12-09 Otsuka Pharma Co Ltd Preparado oral sólido que comprende aripiprazol y un método para producir un preparado oral sólido que comprende aripiprazol
US10525057B2 (en) 2013-09-24 2020-01-07 Otsuka Pharmaceutical Co., Ltd. Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function
WO2015067313A1 (en) 2013-11-07 2015-05-14 Synthon B.V. Orodispersible pharmaceutical compositions comprising aripiprazole
CN106068256B (zh) 2013-12-20 2020-10-23 艾吉因生物股份有限公司 用于治疗认知损害的苯并二氮杂*衍生物、组合物和方法
AU2015231278B2 (en) 2014-03-20 2020-01-23 Alkermes Pharma Ireland Limited Aripiprazole formulations having increased injection speeds
KR20160139704A (ko) 2015-05-28 2016-12-07 주식회사 씨엠지제약 아리피프라졸을 포함하는 경구용 속용 필름 제제, 및 이의 제조방법
CN107920989A (zh) 2015-06-08 2018-04-17 考里安国际公司 用于透皮递送阿立哌唑的制剂
CN113264939A (zh) 2015-06-19 2021-08-17 艾吉因生物股份有限公司 用于治疗认知损害的苯并二氮杂环庚三烯衍生物、组合物和方法
AU2016282682A1 (en) * 2015-06-22 2018-01-18 Embera Neurotherapeutics, Inc. Compositions and methods for the treatment of substance use disorders, addiction, and psychiatric disorders
CN106608875A (zh) 2015-10-26 2017-05-03 江苏恩华药业股份有限公司 一种稠和杂环类衍生物合成及其应用
AU2017303975A1 (en) 2016-07-28 2019-03-21 Mylan Laboratories Ltd, Process for preparing sterile aripiprazole formulation
CN108069900B (zh) * 2016-11-08 2022-09-23 齐鲁制药有限公司 阿立哌唑盐酸盐的制备方法和用途
TR201617675A2 (tr) 2016-12-02 2018-06-21 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Ari̇pi̇prazole monohi̇drat formülasyonlarinin ağizda dağilan tablet formu
US20180170941A1 (en) 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
BR112019012821A2 (pt) 2016-12-19 2019-11-26 Agenebio Inc derivados de benzodiazepina, composições e métodos para o tratamento do comprometimento cognitivo
US11179377B2 (en) 2017-03-10 2021-11-23 Embera Neurotherapeutics, Inc. Pharmaceutical compositions and uses thereof
JP7246364B2 (ja) 2017-07-28 2023-03-27 インテルキム、ソシエダッド アノニマ アリピプラゾールラウロキシルの調製方法
CN109498556A (zh) * 2017-09-15 2019-03-22 万特制药(海南)有限公司 阿立哌唑口服溶液及其制备方法
EP3761983A1 (en) 2018-03-05 2021-01-13 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy
CN112601749B (zh) 2018-06-19 2024-03-26 艾吉因生物股份有限公司 用于治疗认知损害的苯并二氮杂环庚三烯衍生物，组合物和方法
CN109180577B (zh) * 2018-10-15 2021-11-16 迪嘉药业集团有限公司 一种阿立哌唑的制备方法
KR102128883B1 (ko) 2019-10-02 2020-07-01 (주)삼화바이오팜 고순도 아리피프라졸의 신규 결정형 및 이의 제조방법
WO2022212538A1 (en) * 2021-03-31 2022-10-06 Blueprint Medicines Corporation Diazepanone-fused pyrimidine compounds, compositions and medicinal applications thereof
JP2024529051A (ja) * 2021-08-05 2024-08-01 シューチン バイオファーマ カンパニー リミテッド 三環式誘導体含有調節剤、その製造方法および応用
CN114751873A (zh) * 2022-04-25 2022-07-15 扬州市普林斯医药科技有限公司 一种1-(2,3-二氯苯基)哌嗪的制备方法
US20240132513A1 (en) 2022-08-19 2024-04-25 Agenebio, Inc. Benzazepine derivatives, compositions, and methods for treating cognitive impairment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994900A (en) * 1976-01-23 1976-11-30 E. R. Squibb & Sons, Inc. 6-(Or 8)-[[(substituted amino)alkyl]oxy(or thio)]-3,4-dihydro-4-phenyl-2(1H)-quinolinones
JPS54130587A (en) * 1978-03-30 1979-10-09 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
DE2960178D1 (en) * 1978-06-06 1981-04-09 Hoechst Ag New substituted phenylpiperazine derivatives, pharmaceutical compositions containing them and process for their preparation
DE2827566A1 (de) * 1978-06-23 1980-01-10 Boehringer Mannheim Gmbh 1,2-dihydro-chinolin-2-on-derivate und verfahren zu ihrer herstellung
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
JPS58203968A (ja) * 1982-05-21 1983-11-28 Otsuka Pharmaceut Co Ltd イソカルボスチリル誘導体
CN85108214A (zh) * 1984-11-22 1986-08-20 赫彻斯特股份公司 新的取代的苯基哌嗪衍生物及其药物的制造方法
DK588486A (da) * 1985-12-09 1987-06-10 Otsuka Pharma Co Ltd Anvendelse af en forbindelse til behandling af hypoxi

Also Published As

Publication number Publication date
DE68925405T2 (de) 1996-06-27
HK1002706A1 (en) 1998-09-11
NL300161I1 (nl) 2004-12-01
MX9202934A (es) 1992-06-30
CN1042537A (zh) 1990-05-30
EP0367141A2 (en) 1990-05-09
EP0367141A3 (en) 1991-06-12
EP0367141B1 (en) 1996-01-10
DE122004000043I2 (de) 2005-06-16
DE122004000043I1 (de) 2005-02-03
DE68925405D1 (de) 1996-02-22
KR900006320A (ko) 1990-05-07
US5006528A (en) 1991-04-09
DK539789A (da) 1990-05-01
KR0138529B1 (ko) 1998-05-15
DK539789D0 (da) 1989-10-30
CN1028104C (zh) 1995-04-05
DK168485B1 (da) 1994-04-05
ES2084594T3 (es) 1996-05-16

Similar Documents

Publication Publication Date Title
NL300161I2 (nl) Carbostyrilderivaten.
DE69009785D1 (de) Carbostyrilderivate.
DE69008682D1 (de) Guanidinobenzolderivate.
DK391189A (da) Carbostyrilderivater
ATE74350T1 (de) Dehydrocholecalciferolderivate.
ATE124407T1 (de) Chromanderivate.
DE3872153D1 (de) 25-hydroxy-vitamin-d3-derivate.
ATE126800T1 (de) Neplanocinderivate.
DE69017383D1 (de) Substituierte bicycloheptadionderivate.
ATE116985T1 (de) Chromanderivate.
ATE99694T1 (de) Antiparasitaere derivate.
DE68911192D1 (de) Phosphonoalkylpurin-Derivate.
DE69017657D1 (de) Pyridinderivate.
NO891027L (no) Kinolinderivater.
DE58903265D1 (de) Fluorcyclopropyl-derivate.
ATE102624T1 (de) Makrolide derivate.
DE69005904D1 (de) Phenylpyrimidonderivate.
DE59000510D1 (de) N-phenyltetrahydroindazolderivate.
DE68913856D1 (de) Cycloalkylthiazol-Derivate.
DE59003499D1 (de) 3-Cyano-4-phenyl-pyrrol-Derivate.
DE3861208D1 (de) Hydroxyalkyl-triazolyl-derivate.
DE68927179D1 (de) Carbostyril-derivate
DE69015726D1 (de) Piperidylthiocarbapenem-Derivate.
NO892714D0 (no) Substituerte azacykloheksylderivater.
DE58900371D1 (de) 3-cyano-4-phenyl-pyrrol-derivate.